Mechanisms of disease progression in chronic myeloid leukemia

1 Views

07/08/23

Dr. S. Tiong Ong, Duke-NUS Medical School Singapore & Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, NC, USA

Learning goals:

- Understand that BP progression is characterized by a common, or 'core' transcriptome
- Understand that polycomb complex (PCR-)-driven processes contribute to the 'core' transcriptome
- Appreciate that a PCR-based model of CML progression identifies putative CP biomarkers
and therapeutic strategies

This talk was first presented during the Scientific Working Group Session – ELN-EHA-SWG for CML: 'Understanding the pathogenesis of CML' at EHA 2022